FDA Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of FDA Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Clinical Trial Research
Bentley Pharmaceuticals Announces Fourth Quarter and Full Year 2006 Financial Results
March 15th, 2007
Bentley Pharmaceuticals, Inc. (NYSE: BNT), a specialty pharmaceutical company, reported financial results for the fourth quarter and year ended December 31, 2006. For the fourth quarter 2006 consolidated revenues were $27.1 million, a 7% increase from $25.2 million reported in the fourth quarter of 2005. Gross margins on net product sales for quarters ended December 31, 2006 and 2005 were 48.7% and 45.7%, respectively. Operating income for the fourth quarter 2006 was $2.9 million compared with $4.4 million reported in the same quarter of the prior year. The Company noted the lower operating income resulted from increased expenses supporting development of its intranasal...
Source: FDA Law Weekly (2007-03-15)
|
